Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Coherus Oncology, Inc.

CIK: 15127622 Annual ReportsLatest: 2026-03-09

10-K / March 9, 2026

Revenue:$42,172,000
Income:$168,024,000

10-K / March 17, 2025

Revenue:$206,000,000
Income:$28,507,000

10-K / March 9, 2026

Unknown Company

Document

  • Form 10-K, Part I

Part I sections (with pages)

  • Item 1. Business (5)
  • Item 1A. Risk Factors (22)
  • Item 1B. Unresolved Staff Comments (60)
  • Item 1C. Cybersecurity (60)
  • Item 2. Properties (61)
  • Item 3. Legal Proceedings (61)
  • Item 4. Mine Safety Disclosures (61)

Inference

  • The filing follows the standard Part I structure for a Form 10-K.
  • The presence of a Mine Safety Disclosures section is consistent with filings from companies involved in mining or mineral-related operations.

Next steps

Please provide the text for the following sections (or the relevant figures) to produce a detailed, numbers-based summary:

  • Item 1. Business (description of products/services, markets, key customers)
  • Item 8. Financial Statements and Supplementary Data (revenue, net income, and other financial metrics)

Once you share those sections I will summarize:

  • Company overview (core products/services and markets)
  • Number of customers and employees (if stated)
  • Revenue and net income (and other key financial figures provided)
  • Other operational details (geography, major customers, dependencies)